← SynDRA
ELENBECESTAT
SynDRA canonical compound SYN0039316 — structure-anchored drug synonym record
| Clinical phase | Phase 3 |
|---|
| Primary target(s) | BACE1 |
|---|
| Mechanism of action | beta secretase inhibitor |
|---|
| Indication | alzheimer's disease |
|---|
| Disease area | neurology/psychiatry |
|---|
All known targets
Mechanisms of action (all sources)
- BACE1 INHIBITOR
- Beta-secretase 1 inhibitor
- beta secretase inhibitor
Cross-references
Synonyms
- E-2609
- E2609
- Beta secretase inhibitor (Alzheimer's disease), Eisai
- E 2609
- RXJ96XL94H
- elenbecestatum
- RefChem:1084069
- Elenbecestat [INN]
- Elenbecestat [USAN]
- Elenbecestat; E2609
- Elenbecestat (JAN/USAN)
- ELENBECESTAT [JAN]
- Elenbecestat [USAN:INN]
- UNII-RXJ96XL94H
- EMAPALUMAB [WHO-DD]
- ELENBECESTAT [WHO-DD]
- GTPL9818
- orb1309713
- SCHEMBL2620149
- SCHEMBL29359992
- SCHEMBL30477102
- AACUJFVOHGRMTR-DPXNYUHVSA-N
- GLXC-21509
- EX-A3151
- NFC65130
- BDBM50510823
- AKOS040733087
- AC-36887
- DA-73059
- MS-27836
- HY-109055
- CS-0031645
- D11509
- D87146
- T11175
- N-[3-[(4aS,5R,7aS)-2-amino-5-methyl-4,4a,5,7-tetrahydrofuro[3,4-d][1,3]thiazin-7a-yl]-4-fluorophenyl]-5-(difluoromethyl)pyrazine-2-carboxamide
Look up ELENBECESTAT in the interactive SynDRA portal →